ALPS is pleased to share the Preclinical Stem Cell Study publication in reputed PLOS Journal (indexed in reputed pubmed database) published on 24/10/2024.
This preclinical study was for ALPS’ UC-MSC pipeline for its safety and allergic effect, which had affirmed hUC-MSC stem cells meet safety standards for clinical cell therapy, emphasizing their safe and promising clinical utility.
Our preclinical toxicity and allergy effect of Human umbilical cord mesenchymal stem cells paper was published in the PLOS Journal on 24 October 2024.
Title: Human umbilical cord mesenchymal stem cells toxicity and allergy effects: In vivo assessment
Indeed another great new finding for ALPS!
Publication Link: journals.plos.org
